ArticleAIDS research and therapy2025
Evaluating the contribution of operation triple zero to HIV viral load suppression and retention among the adolescents in TASO Uganda using RE-AIM framework: a before and after implementation science study.
Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Factors associated with viral suppression and antiretroviral therapy adherence among adolescents and young adults living with HIV in the African Cohort Study.Journal of acquired immune deficiency syndromes (1999) · 2026Article
- A Systematic Review and Meta-analysis on the Association Between Antiretroviral Therapy Refill Type and Viral Suppression.AIDS and behavior · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAdolescents living with HIV (ALHIV) aged 10-19 years endure sub-optimal viral load suppression (VLS) and retention in care in many settings. We implemented operation triple zero (OTZ) in The AIDS Support Organization (TASO) Soroti and Mbale Centers of Excellence (COEs) to improve VLS and retention. Thus, this study evaluated the contribution of OTZ to improving both treatment outcomes among the ALHIV in the two COEs at one year. METHODOLOGY: This before and after study used Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework to guide secondary data collection from the cohort of ALHIV active in care in the April-June 2022 quarter. Effectiveness was determined by computing the overall VLS rates basing on plasma RNA copies below 1000/ml while retention was based on being active in care at the end of June 2024. A self-report was used to gather fidelity data. Univariates were summarized as frequencies and proportions, Generalized Equation Estimate (GEE) to compute the effect of the model and associated factors at 95% confidence interval and P < 0.05 level of significance. Odds ratio was used to report levels of predictability.
resultsOut of the original 533 ALHIV, 510 were considered for the post-intervention analysis, 53.1% females, mean age of 15.27 (Standard deviation = 2.15). Overall, retention at 12 months improved from 95.9 to 97.3% while VLS from 84 to 92.7% [adjusted OR 1.26 95%CI (0.61-2.61) P = 0.036]. Importantly, there was zero death in the one year of implementation. After adjusting for confounders, adolescents in the facility-based group (FBG) were more likely to be retained in care [adjusted odds ratio (aOR)7.36 95% CI (2.35-23.10) P = 0.001]. Also, multi-month dispensing [aOR 11.65 95%CI (2.93-46.34) P < 0.001] and being in FBG [aOR 9.87 95%CI (4.08-23.88) P < 0.001] and community-based models [aOR 21.96 95%CI (2.68-179.84) P = 0.004] were predictive of good VLS while poor adherence [aOR 0.02 95%CI (0.0037-0.11) P < 0.001] and being male [aOR 0.5 95%CI (0.27-0.91) p = 0.024] were predictors of poor VLS. Fidelity was good, at 80%.
conclusionsOTZ contributed to improved VLS in the setting possibly due to fidelity of enhanced implementation of adolescent friendly health services. We encourage OTZ adaptation in similar settings to strengthen improvements in VLS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.